Greenwood Capital Associates’s Harvard Bioscience HBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.3K Sell
27,754
-735
-3% -$326 ﹤0.01% 249
2025
Q1
$16.1K Sell
28,489
-187,809
-87% -$106K ﹤0.01% 234
2024
Q4
$456K Sell
216,298
-9,568
-4% -$20.2K 0.06% 196
2024
Q3
$608K Buy
225,866
+18,932
+9% +$50.9K 0.08% 172
2024
Q2
$590K Sell
206,934
-9,680
-4% -$27.6K 0.08% 178
2024
Q1
$918K Sell
216,614
-3,989
-2% -$16.9K 0.12% 143
2023
Q4
$1.18M Sell
220,603
-8,957
-4% -$47.9K 0.15% 117
2023
Q3
$987K Buy
229,560
+1,616
+0.7% +$6.95K 0.14% 130
2023
Q2
$1.25M Sell
227,944
-48,422
-18% -$266K 0.18% 103
2023
Q1
$1.16M Sell
276,366
-5,988
-2% -$25.2K 0.17% 115
2022
Q4
$782K Buy
282,354
+4,717
+2% +$13.1K 0.13% 133
2022
Q3
$711K Sell
277,637
-3,864
-1% -$9.9K 0.12% 141
2022
Q2
$1.01M Buy
281,501
+58,522
+26% +$211K 0.16% 111
2022
Q1
$1.39M Buy
222,979
+6,616
+3% +$41.1K 0.36% 49
2021
Q4
$1.53M Buy
216,363
+3,950
+2% +$27.8K 0.22% 87
2021
Q3
$1.48M Buy
212,413
+1,961
+0.9% +$13.7K 0.23% 81
2021
Q2
$1.75M Sell
210,452
-178
-0.1% -$1.48K 0.27% 74
2021
Q1
$1.15M Buy
210,630
+2,912
+1% +$15.9K 0.18% 96
2020
Q4
$891K Buy
207,718
+58,376
+39% +$250K 0.15% 117
2020
Q3
$450K Buy
149,342
+33,764
+29% +$102K 0.09% 133
2020
Q2
$358K Buy
115,578
+7,049
+6% +$21.8K 0.08% 126
2020
Q1
$240K Sell
108,529
-17,429
-14% -$38.5K 0.07% 126
2019
Q4
$384K Buy
125,958
+28,074
+29% +$85.6K 0.08% 128
2019
Q3
$301K Buy
97,884
+21,945
+29% +$67.5K 0.07% 134
2019
Q2
$152K Sell
75,939
-2,268
-3% -$4.54K 0.04% 171
2019
Q1
$337K Buy
78,207
+851
+1% +$3.67K 0.09% 119
2018
Q4
$246K Buy
77,356
+22,647
+41% +$72K 0.06% 148
2018
Q3
$287K Buy
+54,709
New +$287K 0.06% 150